Jiang Yu, Han Qiuju, Zhao Huajun, Zhang Jian
Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan, 250012, Shandong Province, People's Republic of China.
J Hepatocell Carcinoma. 2021 May 20;8:435-450. doi: 10.2147/JHC.S307962. eCollection 2021.
Hepatocellular carcinoma (HCC) is a common malignancy, and the hepatitis B virus (HBV) is its major pathogenic factor. Over the past decades, it has been confirmed that HBV infection could promote disease progression through a variety of mechanisms, ultimately leading to the malignant transformation of liver cells. Many factors have been identified in the pathogenesis of HBV-associated HCC (HBV-HCC), including HBV gene integration, genomic instability caused by mutation, and activation of cancer-promoting signaling pathways. As research in the progression of HBV-HCC progresses, the role of many new mechanisms, such as epigenetics, exosomes, autophagy, metabolic regulation, and immune suppression, is also being continuously explored. The occurrence of HBV-HCC is a complex process caused by interactions across multiple genes and multiple steps, where the synergistic effects of various cancer-promoting mechanisms accelerate the process of disease evolution from inflammation to tumorigenesis. In this review, we aim to provide a brief overview of the mechanisms involved in the occurrence and development of HBV-HCC, which may contribute to a better understanding of the role of HBV in the occurrence and development of HCC.
肝细胞癌(HCC)是一种常见的恶性肿瘤,乙型肝炎病毒(HBV)是其主要致病因素。在过去几十年中,已证实HBV感染可通过多种机制促进疾病进展,最终导致肝细胞的恶性转化。在HBV相关肝细胞癌(HBV-HCC)的发病机制中已确定了许多因素,包括HBV基因整合、由突变引起的基因组不稳定以及促癌信号通路的激活。随着对HBV-HCC进展的研究不断深入,许多新机制的作用,如表观遗传学、外泌体、自噬、代谢调节和免疫抑制,也在不断探索中。HBV-HCC的发生是一个由多个基因和多个步骤相互作用引起的复杂过程,其中各种促癌机制的协同作用加速了疾病从炎症到肿瘤发生的演变过程。在本综述中,我们旨在简要概述HBV-HCC发生和发展所涉及的机制,这可能有助于更好地理解HBV在HCC发生和发展中的作用。